Australian Broker Call
Produced and copyrighted by at www.fnarena.com
March 23, 2018
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
Last Updated: 12:45 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
MIN - | MINERAL RESOURCES | Downgrade to Accumulate from Buy | Ord Minnett |
SM1 - | SYNLAIT MILK | Downgrade to Underperform from Neutral | Macquarie |
SXY - | SENEX ENERGY | Downgrade to Sell from Neutral | Citi |
BKW BRICKWORKS LIMITED
Building Products & Services
More Research Tools In Stock Analysis - click HERE
Overnight Price: $15.65
Citi rates BKW as Neutral (3) -
Citi found first half results hard to fault as strong building activity continues along the east coast. The broker believes the company's diversified model, where property and investments account for two thirds of earnings, is proving its worth.
Nevertheless, the broker believes FY18 earnings will prove to be the peak and further upside is limited. Neutral retained. Target is lifted to $16.20 from $15.08.
Target price is $16.20 Current Price is $15.65 Difference: $0.55
If BKW meets the Citi target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $15.75, suggesting upside of 0.6% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY18:
Citi forecasts a full year FY18 dividend of 54.00 cents and EPS of 142.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 126.4, implying annual growth of 1.2%. Current consensus DPS estimate is 52.8, implying a prospective dividend yield of 3.4%. Current consensus EPS estimate suggests the PER is 12.4. |
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 58.90 cents and EPS of 115.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 114.0, implying annual growth of -9.8%. Current consensus DPS estimate is 55.0, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 13.7. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates BKW as Neutral (3) -
First half results were ahead of expectations. Macquarie expects the residential cycle to continue supporting building products while the property business is a store of value for the group.
However, no catalyst is envisaged that will drive a meaningful re-rating at this stage. Target is raised to $15.60 from $14.46. Neutral maintained.
Target price is $15.60 Current Price is $15.65 Difference: minus $0.05 (current price is over target).
If BKW meets the Macquarie target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $15.75, suggesting upside of 0.6% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY18:
Macquarie forecasts a full year FY18 dividend of 54.00 cents and EPS of 134.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 126.4, implying annual growth of 1.2%. Current consensus DPS estimate is 52.8, implying a prospective dividend yield of 3.4%. Current consensus EPS estimate suggests the PER is 12.4. |
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 56.00 cents and EPS of 125.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 114.0, implying annual growth of -9.8%. Current consensus DPS estimate is 55.0, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 13.7. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates BKW as Hold (3) -
First half results were ahead of expectations and Morgans upgrades FY18 estimates for operating earnings by 20%.
Building products stood out, although with activity slowing and higher energy costs Morgans suggests earnings growth over the next few years will be more challenging.
This should be mitigated by the cross holding in WH Soul Pattinson ((SOL)) and increased property activity, the broker suggests. Hold rating. Target rises to $15.61 from $13.94.
Target price is $15.61 Current Price is $15.65 Difference: minus $0.04 (current price is over target).
If BKW meets the Morgans target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $15.75, suggesting upside of 0.6% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY18:
Morgans forecasts a full year FY18 dividend of 52.00 cents and EPS of 126.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 126.4, implying annual growth of 1.2%. Current consensus DPS estimate is 52.8, implying a prospective dividend yield of 3.4%. Current consensus EPS estimate suggests the PER is 12.4. |
Forecast for FY19:
Morgans forecasts a full year FY19 dividend of 54.00 cents and EPS of 120.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 114.0, implying annual growth of -9.8%. Current consensus DPS estimate is 55.0, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 13.7. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $11.22
Morgan Stanley rates BOQ as Underweight (5) -
Morgan Stanley expects slowing earnings growth will be revealed when the bank reports in April. Margins are peaking, although there may be some support from improved loan growth.
Morgan Stanley notes good cost controls and credit quality could surprise positively. The broker suggests investment in digital will take priority over further capital returns.
Underweight maintained. Target is reduced to $11.00 from $11.40. In-Line industry view retained.
Target price is $11.00 Current Price is $11.22 Difference: minus $0.22 (current price is over target).
If BOQ meets the Morgan Stanley target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $12.06, suggesting upside of 7.5% (ex-dividends)
The company's fiscal year ends in August.
Forecast for FY18:
Morgan Stanley forecasts a full year FY18 dividend of 76.00 cents and EPS of 93.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 95.1, implying annual growth of -2.6%. Current consensus DPS estimate is 78.6, implying a prospective dividend yield of 7.0%. Current consensus EPS estimate suggests the PER is 11.8. |
Forecast for FY19:
Morgan Stanley forecasts a full year FY19 dividend of 76.00 cents and EPS of 94.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 95.3, implying annual growth of 0.2%. Current consensus DPS estimate is 77.6, implying a prospective dividend yield of 6.9%. Current consensus EPS estimate suggests the PER is 11.8. |
Market Sentiment: -0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.41
Macquarie rates KLL as Outperform (1) -
The company has updated on evaporation pond and harvesting trials, having signed an agreement that could see additional revenue from the sale of salt from the Beyondie project.
Macquarie believes the trials significantly de-risk the development. Completion of the bankable feasibility study in the next few months should enable the company to move to full-scale development later in the year. Outperform rating and $0.60 target maintained.
Target price is $0.60 Current Price is $0.41 Difference: $0.19
If KLL meets the Macquarie target it will return approximately 46% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY18:
Macquarie forecasts a full year FY18 dividend of 0.00 cents and EPS of minus 5.90 cents. |
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 2.80 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $17.50
Ord Minnett rates MIN as Downgrade to Accumulate from Buy (2) -
Given recent share price strength, Ord Minnett downgrades its recommendation to Accumulate from Buy and lowers the target to $19.50 from $20.50.
The broker notes ASX lithium companies have largely recovered from recent concerns about oversupply. The broker prefers Orocobre ((ORE)), Galaxy Resources ((GXY)) and Kidman Resources ((KDR)) in the sector.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $19.50 Current Price is $17.50 Difference: $2
If MIN meets the Ord Minnett target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $20.85, suggesting upside of 19.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY18:
Ord Minnett forecasts a full year FY18 dividend of 65.00 cents and EPS of 192.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 160.3, implying annual growth of 48.9%. Current consensus DPS estimate is 67.6, implying a prospective dividend yield of 3.9%. Current consensus EPS estimate suggests the PER is 10.9. |
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 104.00 cents and EPS of 260.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 241.3, implying annual growth of 50.5%. Current consensus DPS estimate is 109.4, implying a prospective dividend yield of 6.3%. Current consensus EPS estimate suggests the PER is 7.3. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.80
Citi rates SIG as Sell (5) -
Citi continues to believe the stock is overvalued relative to the ASX Industrials because of the structural challenges associated with the base business and the execution of its capital deployment plan.
FY19 guidance of around $90m in earnings (EBIT) suggests the base business is going backwards, since acquisitions should contribute over $3m.
The broker believes there is poor prospect for the PBS distribution business because of rising volumes and costs and assumes the company progressively loses Chemist Warehouse as a customer at the end of its current service contract in June 2019.
Sell rating maintained. Target is reduced to $0.70 from $0.74.
Target price is $0.70 Current Price is $0.80 Difference: minus $0.1 (current price is over target).
If SIG meets the Citi target it will return approximately minus 13% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $0.77, suggesting downside of -4.1% (ex-dividends)
The company's fiscal year ends in January.
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 4.80 cents and EPS of 5.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of -7.1%. Current consensus DPS estimate is 4.9, implying a prospective dividend yield of 6.1%. Current consensus EPS estimate suggests the PER is 15.4. |
Forecast for FY20:
Citi forecasts a full year FY20 dividend of 3.50 cents and EPS of 4.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of N/A. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 15.4. |
Market Sentiment: -0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates SIG as Neutral (3) -
FY18 results were in line with expectations. Credit Suisse expects PBS revenues to remain under pressure as some manufacturers are choosing to by-pass wholesale distributors and go directly to pharmacies.
Higher growth of non-PBS revenue and the potential winding back of the remaining trade discounts to pharmacy should raise gross profits through FY19.
Credit Suisse retains a Neutral rating and reduces the target to $0.82 from $0.84.
Target price is $0.82 Current Price is $0.80 Difference: $0.02
If SIG meets the Credit Suisse target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $0.77, suggesting downside of -4.1% (ex-dividends)
The company's fiscal year ends in January.
Forecast for FY19:
Credit Suisse forecasts a full year FY19 dividend of 5.00 cents and EPS of 5.42 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of -7.1%. Current consensus DPS estimate is 4.9, implying a prospective dividend yield of 6.1%. Current consensus EPS estimate suggests the PER is 15.4. |
Forecast for FY20:
Credit Suisse forecasts a full year FY20 dividend of 5.25 cents and EPS of 5.59 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of N/A. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 15.4. |
Market Sentiment: -0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates SIG as Underweight (5) -
FY18 results were broadly in line with lowered expectations. FY19 guidance is reiterated and no growth is expected.
Morgan Stanley observes the second half performance became more challenged as the year progressed, firstly from Chemist Warehouse disruption and subsequently from broader-based industry challenges. The broker suggests this is not the optimal time to be investing for growth.
Underweight rating. Target is raised to $0.80 from $0.79. Industry view is In-Line.
Target price is $0.80 Current Price is $0.80 Difference: $0
If SIG meets the Morgan Stanley target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $0.77, suggesting downside of -4.1% (ex-dividends)
The company's fiscal year ends in January.
Forecast for FY19:
Morgan Stanley forecasts a full year FY19 dividend of 4.90 cents and EPS of 5.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of -7.1%. Current consensus DPS estimate is 4.9, implying a prospective dividend yield of 6.1%. Current consensus EPS estimate suggests the PER is 15.4. |
Forecast for FY20:
Morgan Stanley forecasts a full year FY20 dividend of 4.90 cents and EPS of 5.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of N/A. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 15.4. |
Market Sentiment: -0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates SIG as Sell (5) -
FY18 results were broadly in line and remind UBS of the difficulties faced by pharmacy wholesalers. With operating expenditure running ahead of sales growth, the broker expects the challenging earnings environment to continue.
The company expects negotiations with Chemist Warehouse to continue over the balance of 2018. The current supply deal is set to lapse in June 2019.
UBS considers the share price reaction to the results is a reality check to investor expectations rather than a sign of anything operational. Sell rating maintained. Target is raised to $0.75 from $0.70.
Target price is $0.75 Current Price is $0.80 Difference: minus $0.05 (current price is over target).
If SIG meets the UBS target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $0.77, suggesting downside of -4.1% (ex-dividends)
The company's fiscal year ends in January.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 5.00 cents and EPS of 5.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of -7.1%. Current consensus DPS estimate is 4.9, implying a prospective dividend yield of 6.1%. Current consensus EPS estimate suggests the PER is 15.4. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 5.00 cents and EPS of 6.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 5.2, implying annual growth of N/A. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 15.4. |
Market Sentiment: -0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $8.30
Macquarie rates SM1 as Downgrade to Underperform from Neutral (5) -
First half results were ahead of Macquarie's forecasts. No quantitative guidance was provided for the second half but this is expected to be softer because of some margin benefits in the first half.
Macquarie downgrades to Underperform from Neutral on valuation. The strong result was supported by the success of key customers and earnings are expected to grow as infant formula volumes ramp up.
Price target is raised to NZ$7.00 from NZ$5.29.
Current Price is $8.30. Target price not assessed.
Current consensus price target is N/A
The company's fiscal year ends in July.
Forecast for FY18:
Macquarie forecasts a full year FY18 dividend of 0.00 cents and EPS of 38.49 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 39.2, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 21.2. |
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of 45.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 47.4, implying annual growth of 20.9%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 17.5. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.39
Citi rates SXY as Downgrade to Sell from Neutral (5) -
Citi has downgraded to Sell/High Risk from Neutral/High Risk following a recent rally in the share price. Target price remains untouched at 35c.
As Citi has also increased its in-house forecasts for Brent and WTI oil prices by US$6 in 3Q18 to US$60/bbl and US$58/bbl respectively, earnings estimates have been lifted.
While pointing out there remains significant upside value potential, risks remain as well around well performance, cost control, gas contract pricing, funding and execution. As a result, investors are unlikely to pay up for the potential as yet, suggest the analysts.
Target price is $0.35 Current Price is $0.39 Difference: minus $0.04 (current price is over target).
If SXY meets the Citi target it will return approximately minus 10% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $0.41, suggesting upside of 5.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY18:
Citi forecasts a full year FY18 dividend of 0.00 cents and EPS of minus 0.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -2.1, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 1.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 10.2, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 3.8. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $41.96
Deutsche Bank rates WES as Hold (3) -
A disappointing financial update by Kingfisher in the UK has once again highlighted to Deutsche Bank that the UK home improvement market is doing it tough. The analysts suggest this deterioration is compounding the errors made by BUKI (Wesfarmers).
While Wesfarmers won't be making drastic decisions based on cyclical moves, the analysts nevertheless believe the odds are shortening the board might approve an early exit. If this is the case, it will be a costly exercise, the analysts add, given the tough market.
Deutsche Bank's current valuation for Wesfarmers incorporates a costly exit to the tune of -$2bn. Hold rating retained, as well as $40 price target.
Target price is $40.00 Current Price is $41.96 Difference: minus $1.96 (current price is over target).
If WES meets the Deutsche Bank target it will return approximately minus 5% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $43.06, suggesting upside of 2.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY18:
Deutsche Bank forecasts a full year FY18 dividend of 223.00 cents and EPS of 247.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 231.7, implying annual growth of -9.0%. Current consensus DPS estimate is 216.6, implying a prospective dividend yield of 5.2%. Current consensus EPS estimate suggests the PER is 18.1. |
Forecast for FY19:
Deutsche Bank forecasts a full year FY19 dividend of 225.00 cents and EPS of 252.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 250.9, implying annual growth of 8.3%. Current consensus DPS estimate is 219.0, implying a prospective dividend yield of 5.2%. Current consensus EPS estimate suggests the PER is 16.7. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Summaries
BKW | BRICKWORKS | Neutral - Citi | Overnight Price $15.65 |
Neutral - Macquarie | Overnight Price $15.65 | ||
Hold - Morgans | Overnight Price $15.65 | ||
BOQ | BANK OF QUEENSLAND | Underweight - Morgan Stanley | Overnight Price $11.22 |
KLL | KALIUM LAKES | Outperform - Macquarie | Overnight Price $0.41 |
MIN | MINERAL RESOURCES | Downgrade to Accumulate from Buy - Ord Minnett | Overnight Price $17.50 |
SIG | SIGMA HEALTHCARE | Sell - Citi | Overnight Price $0.80 |
Neutral - Credit Suisse | Overnight Price $0.80 | ||
Underweight - Morgan Stanley | Overnight Price $0.80 | ||
Sell - UBS | Overnight Price $0.80 | ||
SM1 | SYNLAIT MILK | Downgrade to Underperform from Neutral - Macquarie | Overnight Price $8.30 |
SXY | SENEX ENERGY | Downgrade to Sell from Neutral - Citi | Overnight Price $0.39 |
WES | WESFARMERS | Hold - Deutsche Bank | Overnight Price $41.96 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 1 |
2. Accumulate | 1 |
3. Hold | 5 |
5. Sell | 6 |
Friday 23 March 2018
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
1 |
ASX Winners And Losers Of Today – 08-10-24Oct 08 2024 - Daily Market Reports |
2 |
Australian Broker Call *Extra* Edition – Oct 08, 2024Oct 08 2024 - Daily Market Reports |
3 |
BHP Shares Eyeing Return To $50Oct 08 2024 - Technicals |
4 |
Audinate’s Recurring Revenue OpportunityOct 08 2024 - Small Caps |
5 |
Weekly Update On LICs & LITs – 07-Oct-2024Oct 08 2024 - Weekly Reports |